Antiviral activity of inhibitors of pyrimidine de-novo biosynthesis

M. Wachsman, F. M. Hamzeh, N. B. Assadi, P. S. Lietman

Research output: Contribution to journalArticle

Abstract

Evaluation of the elevation of host cell biosynthesis of deoxynucleoside triphosphates (dNTP's) induced by human cytomegalovirus (HCMV) infection as a target for antiviral therapeutics was carried out. The concentrations of all four intracellular dNTP's rose rapidly following HCMV infection, and were markedly above baseline by 8 h post infection (p.i.). All tour deoxynucleoside triphosphates remained elevated above baseline for at least 72 h p.i. The effects of inhibitors of the de-novo pathway of pyrimidine biosynthesis on HCMV viral replication were quantified by DNA dot blot. All pyrimidine biosynthesis inhibitors examined inhibited the HCMV DNA replication at concentrations that were non-toxic to the cell. These drugs were also more effective against HCMV, which is highly dependent on host de-novo synthesis, than against HSV-1 which encodes enzymes capable of increasing the supply of dNTP's. The antiviral effect of brequinar, an inhibitor of one of the enzymes of the de-novo pathway (dihydro-orotate dehydrogenase), was examined to determine if it coincided with a decrease in dNTP's. HCMV-infected fibroblasts and uninfected control cells were treated with a concentration of brequinar able to inhibit HCMV DNA levels 90%. It was found that brequinar markedly lowered the levels of dTTP found in treated cells compared to untreated cells in both HCMV-infected and uninfected cells.

Original languageEnglish (US)
Pages (from-to)7-13
Number of pages7
JournalAntiviral Chemistry and Chemotherapy
Volume7
Issue number1
StatePublished - Jan 1996

Fingerprint

Antiviral Agents
brequinar
Cytomegalovirus
Cytomegalovirus Infections
pyrimidine
DNA
Human Herpesvirus 1
Enzyme Inhibitors
Infection
DNA Replication
Fibroblasts
triphosphoric acid
Enzymes
Pharmaceutical Preparations

Keywords

  • Acivicin
  • Antiviral
  • Azaserine
  • Brequinar
  • Cytomegalovirus
  • Deoxynucleotide metabolism

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Wachsman, M., Hamzeh, F. M., Assadi, N. B., & Lietman, P. S. (1996). Antiviral activity of inhibitors of pyrimidine de-novo biosynthesis. Antiviral Chemistry and Chemotherapy, 7(1), 7-13.

Antiviral activity of inhibitors of pyrimidine de-novo biosynthesis. / Wachsman, M.; Hamzeh, F. M.; Assadi, N. B.; Lietman, P. S.

In: Antiviral Chemistry and Chemotherapy, Vol. 7, No. 1, 01.1996, p. 7-13.

Research output: Contribution to journalArticle

Wachsman, M, Hamzeh, FM, Assadi, NB & Lietman, PS 1996, 'Antiviral activity of inhibitors of pyrimidine de-novo biosynthesis', Antiviral Chemistry and Chemotherapy, vol. 7, no. 1, pp. 7-13.
Wachsman M, Hamzeh FM, Assadi NB, Lietman PS. Antiviral activity of inhibitors of pyrimidine de-novo biosynthesis. Antiviral Chemistry and Chemotherapy. 1996 Jan;7(1):7-13.
Wachsman, M. ; Hamzeh, F. M. ; Assadi, N. B. ; Lietman, P. S. / Antiviral activity of inhibitors of pyrimidine de-novo biosynthesis. In: Antiviral Chemistry and Chemotherapy. 1996 ; Vol. 7, No. 1. pp. 7-13.
@article{fc8779b8f2334b97bfc6f33d20fb3222,
title = "Antiviral activity of inhibitors of pyrimidine de-novo biosynthesis",
abstract = "Evaluation of the elevation of host cell biosynthesis of deoxynucleoside triphosphates (dNTP's) induced by human cytomegalovirus (HCMV) infection as a target for antiviral therapeutics was carried out. The concentrations of all four intracellular dNTP's rose rapidly following HCMV infection, and were markedly above baseline by 8 h post infection (p.i.). All tour deoxynucleoside triphosphates remained elevated above baseline for at least 72 h p.i. The effects of inhibitors of the de-novo pathway of pyrimidine biosynthesis on HCMV viral replication were quantified by DNA dot blot. All pyrimidine biosynthesis inhibitors examined inhibited the HCMV DNA replication at concentrations that were non-toxic to the cell. These drugs were also more effective against HCMV, which is highly dependent on host de-novo synthesis, than against HSV-1 which encodes enzymes capable of increasing the supply of dNTP's. The antiviral effect of brequinar, an inhibitor of one of the enzymes of the de-novo pathway (dihydro-orotate dehydrogenase), was examined to determine if it coincided with a decrease in dNTP's. HCMV-infected fibroblasts and uninfected control cells were treated with a concentration of brequinar able to inhibit HCMV DNA levels 90{\%}. It was found that brequinar markedly lowered the levels of dTTP found in treated cells compared to untreated cells in both HCMV-infected and uninfected cells.",
keywords = "Acivicin, Antiviral, Azaserine, Brequinar, Cytomegalovirus, Deoxynucleotide metabolism",
author = "M. Wachsman and Hamzeh, {F. M.} and Assadi, {N. B.} and Lietman, {P. S.}",
year = "1996",
month = "1",
language = "English (US)",
volume = "7",
pages = "7--13",
journal = "Antiviral Chemistry and Chemotherapy",
issn = "0956-3202",
publisher = "International Medical Press Ltd",
number = "1",

}

TY - JOUR

T1 - Antiviral activity of inhibitors of pyrimidine de-novo biosynthesis

AU - Wachsman, M.

AU - Hamzeh, F. M.

AU - Assadi, N. B.

AU - Lietman, P. S.

PY - 1996/1

Y1 - 1996/1

N2 - Evaluation of the elevation of host cell biosynthesis of deoxynucleoside triphosphates (dNTP's) induced by human cytomegalovirus (HCMV) infection as a target for antiviral therapeutics was carried out. The concentrations of all four intracellular dNTP's rose rapidly following HCMV infection, and were markedly above baseline by 8 h post infection (p.i.). All tour deoxynucleoside triphosphates remained elevated above baseline for at least 72 h p.i. The effects of inhibitors of the de-novo pathway of pyrimidine biosynthesis on HCMV viral replication were quantified by DNA dot blot. All pyrimidine biosynthesis inhibitors examined inhibited the HCMV DNA replication at concentrations that were non-toxic to the cell. These drugs were also more effective against HCMV, which is highly dependent on host de-novo synthesis, than against HSV-1 which encodes enzymes capable of increasing the supply of dNTP's. The antiviral effect of brequinar, an inhibitor of one of the enzymes of the de-novo pathway (dihydro-orotate dehydrogenase), was examined to determine if it coincided with a decrease in dNTP's. HCMV-infected fibroblasts and uninfected control cells were treated with a concentration of brequinar able to inhibit HCMV DNA levels 90%. It was found that brequinar markedly lowered the levels of dTTP found in treated cells compared to untreated cells in both HCMV-infected and uninfected cells.

AB - Evaluation of the elevation of host cell biosynthesis of deoxynucleoside triphosphates (dNTP's) induced by human cytomegalovirus (HCMV) infection as a target for antiviral therapeutics was carried out. The concentrations of all four intracellular dNTP's rose rapidly following HCMV infection, and were markedly above baseline by 8 h post infection (p.i.). All tour deoxynucleoside triphosphates remained elevated above baseline for at least 72 h p.i. The effects of inhibitors of the de-novo pathway of pyrimidine biosynthesis on HCMV viral replication were quantified by DNA dot blot. All pyrimidine biosynthesis inhibitors examined inhibited the HCMV DNA replication at concentrations that were non-toxic to the cell. These drugs were also more effective against HCMV, which is highly dependent on host de-novo synthesis, than against HSV-1 which encodes enzymes capable of increasing the supply of dNTP's. The antiviral effect of brequinar, an inhibitor of one of the enzymes of the de-novo pathway (dihydro-orotate dehydrogenase), was examined to determine if it coincided with a decrease in dNTP's. HCMV-infected fibroblasts and uninfected control cells were treated with a concentration of brequinar able to inhibit HCMV DNA levels 90%. It was found that brequinar markedly lowered the levels of dTTP found in treated cells compared to untreated cells in both HCMV-infected and uninfected cells.

KW - Acivicin

KW - Antiviral

KW - Azaserine

KW - Brequinar

KW - Cytomegalovirus

KW - Deoxynucleotide metabolism

UR - http://www.scopus.com/inward/record.url?scp=0030034947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030034947&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030034947

VL - 7

SP - 7

EP - 13

JO - Antiviral Chemistry and Chemotherapy

JF - Antiviral Chemistry and Chemotherapy

SN - 0956-3202

IS - 1

ER -